Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,976,580
in 4 filings, $5.0M under 10b5-1 plans

Net −$4,976,580. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loeillot Olivier −$5.0M Chief Executive Officer sold 37% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-10-29 BARTHELEMY NICOLAS Director Sale −360 $288.19 $104K 1,547
2021-10-29 BARTHELEMY NICOLAS Director Exercise or conversion · Stock Option (Right to Buy) +1,285 0
2021-09-14 DAWES KAREN A Director Sale −13 $290.02 $4K 93,908
2021-09-14 DAWES KAREN A Director Sale −25 $292.34 $7K 93,883
2021-09-14 DAWES KAREN A Director Sale −101 $294.06 $30K 93,782
2021-09-14 DAWES KAREN A Director Sale −108 $295.02 $32K 93,674
2021-09-14 DAWES KAREN A Director Sale −27 $295.82 $8K 93,647
2021-09-09 Hunt Anthony Chief Executive Officer Exercise or conversion +25,000 $32.40 $810K 214,495
2021-09-09 Hunt Anthony Chief Executive Officer Sale −8,536 $294.22 $2.5M 205,959
2021-09-09 Hunt Anthony Chief Executive Officer Sale −14,825 $294.90 $4.4M 191,134
2021-09-09 Hunt Anthony Chief Executive Officer Sale −1,631 $296.09 $483K 189,503
2021-09-09 Hunt Anthony Chief Executive Officer Sale −8 $296.58 $2K 189,495
2021-09-09 Hunt Anthony Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) +25,000 25,154
2021-09-01 Gebski Christine Sale −3,377 $285.33 $964K 33,318
2021-09-01 DAWES KAREN A Director Exercise or conversion −3,459 $38.76 $134K 97,380
2021-09-01 DAWES KAREN A Director Sale −239 $280.27 $67K 97,141
2021-09-01 DAWES KAREN A Director Sale −196 $281.68 $55K 96,945
2021-09-01 DAWES KAREN A Director Sale −405 $282.53 $114K 96,540
2021-09-01 DAWES KAREN A Director Sale −661 $283.56 $187K 95,879
2021-09-01 DAWES KAREN A Director Sale −1,107 $284.64 $315K 94,772

Page 25 of 42 · 832 trades